Searched for
RSV VACCINE
CDC cuts childhood vaccine list to match Denmark model, sparks public health concernsThe CDC has changed the US childhood vaccine schedule and now recommends fewer routine shots, closer to Denmark’s model. Health officials s...- Dr Reddy's to introduce Sanofi's novel drug in IndiaDr. Reddy's Laboratories has expanded its partnership with Sanofi Healthcare to introduce Beyfortus, a novel drug preventing lower respirat...
- Is US staring at a ‘quad-demic’? Flu, COVID-19, RSV, norovirus surge nationwideThe United States is facing a surge in influenza, COVID-19, RSV and norovirus, raising concerns about a potential ‘quad-demic’.
- Quad-demic warning: As 4 diseases spread parallelly at the same time, here are top tips doctors are sharing to protect yourselfIn a recent development it has been known that numerous Public Health officials which includes renowned doctors as well have shared the bes...
- HMPV and COVID-19: Similarities, differences, and is there a vaccine?The outbreak of Human Metapneumovirus (HMPV) in China has raised international alarm, evoking comparisons to the COVID-19 pandemic that pro...
- Quad-demic threat in US: Mask mandate returns as winter viruses surge. What should you do to prevent it?Quad-demic threat has been looming across the US as winter viruses have seen a massive surge. The surge in infections have forced the autho...
- Planning to have a blast at New Year's eve? Be careful; 13 U.S states have been listed as having "very high" respiratory virus activityAs the New Year’s Eve comes pretty close, the respiratory illness activity in the US has gone up and CDC at the same time have issued a war...
- Winter warning: Killer lung virus emerges as tripledemic fears grow; here's all you need to know about itHealth experts warn of a tripledemic this winter due to increased cases of RSV, flu, and COVID-19. RSV, which is particularly dangerous for...
- Vaccine maker Moderna forecasts lower sales next year, shares tumble 17% to near four-year lowModerna has delayed its break-even goal by two years, pushing it to 2028, due to slower regulatory processes for key products like flu and ...
- Sanofi gets drug regulator nod to market RSV therapy in IndiaFrench drugmaker Sanofi announced on Thursday that it has received approval from India's Central Drugs Standard Control Organization (CDSCO...
- Pfizer Q1 Results: Co lifts profit view on cost cuts, smaller drop in PaxlovidPfizer lifted its annual earnings forecast on Wednesday and reported a first-quarter profit above Wall Street estimates, boosted by cost cu...
- Three viruses behind Covid-like symptoms, testing key: DoctorsIndia, which is also seeing a slight uptick in Covid cases, recorded 761 new cases on Friday and 12 deaths due to the viral disease. The nu...
- Coronavirus in US: Covid JN.1 subvariant raises fears ahead of Christmas. How to remain safe during New Year holiday period?Covid JN.1 subvariant has raised concerns ahead of the Christmas. However, it's not the time to panic as a few precautions may help against...
- What is RSV affecting children this winter? Know about symptoms and treatmentRespiratory Syncytial Virus or RSV is a viral disease that infects young children. The disease shows mild symptoms but can be serious and l...
- Unlike Pfizer, Moderna can meet 2023 COVID forecast, analysts sayModerna, the COVID-19 vaccine manufacturer, is poised to meet its 2023 sales target as it taps into the private market. Analysts suggest th...
- US approves maternal vaccine to prevent RSV in infantsThe Pfizer shot, which was already approved for use in older adults, has now been greenlighted for use as a single injection from 32 throug...
- US FDA approves first RSV vaccine from GSKThe approval makes GSK, which has been neck-and-neck with Pfizer in RSV vaccine development, the first company to tap into a multi-billion-...
- Moderna to keep testing flu shot as it fails to meet 'early success' criteriaData from the second trial comes two months after its flu vaccine generated a strong immune response against influenza A strains, but was i...
- GSK's RSV vaccine succeeds in late-stage trial for older adultsThe RSV vaccine is a key component of the British drugmaker's plans to boost its drug development success rate as it prepares to spin off i...
- Respiratory Syncytial Virus: What is it? Why are child cases surging in the wake of COVID-19?So why is RSV, considered a winter illness, peaking in the summer of 2021? Simply put, restrictions put in place for preventing the spread ...
Load More
